Status:
COMPLETED
Smoking Cessation Intervention for Diabetic Patients
Lead Sponsor:
Rhode Island Hospital
Conditions:
Smoking
Type 2 Diabetes
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
This study is designed to develop and test a smoking cessation intervention for smokers with Type 2 diabetes.
Detailed Description
Individuals with Type 2 diabetes smoke at rates similar to those found in the general population, and the health consequences of smoking are particularly severe among smokers with diabetes. In fact, t...
Eligibility Criteria
Inclusion
- 21 years of age or older
- Type 2 diabetes
- regular smoker for at least 3 years
- smoke an average of more than 10 cigarettes per day
- report motivation to quit smoking of at least 5 out of 10
- speak English
Exclusion
- current alcohol abuse or dependence
- current substance abuse or dependence (excluding nicotine)
- psychotic
- form of diabetes other than Type 2
- medical condition that is a contraindication for the transdermal nicotine patch
- using pharmacotherapy for smoking cessation
- using other tobacco products
- unable to provide names and contact information for locators
- no access to a telephone
Key Trial Info
Start Date :
December 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2016
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01501877
Start Date
December 1 2011
End Date
June 1 2016
Last Update
April 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rhode Island Hospital
Providence, Rhode Island, United States, 02903